Exopharm Limited announced that Ms. Elizabeth McGregor, non-executive Director since 5 January 2021 has resigned from the Board effective from 20 December 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0275 AUD | +10.00% | -.--% | -.--% |
Feb. 26 | Exopharm Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
2023 | Exopharm to Cut CEO Role Amid Cost Reductions | MT |
1st Jan change | Capi. | |
---|---|---|
-.--% | 3.15M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- EX1 Stock
- News Exopharm Limited
- Exopharm Limited Announces Resignation of Elizabeth McGregor as Non-Executive Director